The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: Implication for expectant management

被引:51
作者
Ochiai, A [1 ]
Troncoso, P [1 ]
Chen, ME [1 ]
Lloreta, J [1 ]
Babaian, RJ [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Unit 446, Houston, TX 77030 USA
关键词
prostate; prostatic neoplasms; biopsy; tumor burden;
D O I
10.1097/01.ju.0000181211.49267.43
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We assessed the relationship between the number of positive cores obtained at extended biopsy and tumor volume in radical prostatectomy specimens as a tool for predicting the biological significance of prostate cancer from biopsy data. Materials and Methods: The study group included 207 men who were treated with radical prostatectomy without neoadjuvant therapy at our cancer center. All patients were diagnosed by systematic extended biopsy (10 or 11 cores) performed between 1997 and 2003. The variables analyzed were patient age, prostate specific antigen, clinical stage, biopsy Gleason score, maximum tumor length in a core, greatest percent of tumor in a core, total tumor length, total percent of tumor in all cores, positive core location, initial or repeat biopsy and prostate volume in subgroups based on the number of positive cores, that is group 1-1, group 2-2 and group 3-3 or more cores. Bivariate correlation analysis and multiple logistic regression analysis were used to determine the predictors of insignificant cancer. Results: The number of positive cores was significantly related to total tumor volume (r = 0.433, p < 0.001). Insignificant prostate cancer (volume less than 0.5 cc and Gleason score 6 or less) was found in 21.7% of patients (45 of 207). The incidence of insignificant cancer was 42.5% (31 of 73 patients) in group 1, 16.4% (10 of 61) in group 2 and 5.5% (4 of 73) in group 3. There was a significant difference in the incidence of insignificant cancer among the subgroups (group 1 vs 2 p < 0.001, group 1 vs 3 p < 0.0001 and group 2 vs 3 p < 0.05). The best model for predicting insignificant cancer in group 1 was the combination of tumor length less than 2 mm, Gleason score 3 + 4 or less and prostate volume greater than 50 cc with 83.9% sensitivity (26 of 31 patients) and 61.9% specificity (26 of 42). Conclusions: The probability of insignificant cancer was directly related to the number of positive cores. Tumor length in a core, Gleason score and prostate volume significantly enhanced the prediction model for insignificant cancer in men with 1 positive core who underwent extended biopsy.
引用
收藏
页码:2164 / 2168
页数:5
相关论文
共 21 条
  • [1] Relating biopsy and clinical variables to radical prostatectomy findings: Can insignificant and advanced prostate cancer be predicted in a screening population?
    Anast, JW
    Andriole, GL
    Bismar, TA
    Yan, Y
    Humphrey, PA
    [J]. UROLOGY, 2004, 64 (03) : 544 - 550
  • [2] Insignificant prostate cancer in radical prostatectomy specimen: Time trends and preoperative prediction
    Augustin, H
    Hammerer, PG
    Graefen, M
    Erbersdobler, A
    Blonski, J
    Palisaar, J
    Daghofer, F
    Huland, H
    [J]. EUROPEAN UROLOGY, 2003, 43 (05) : 455 - 460
  • [3] Babaian RJ, 2001, CANCER, V91, P1414
  • [4] A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy
    Babaian, RJ
    Toi, A
    Kamoi, K
    Troncoso, P
    Sweet, J
    Evans, R
    Johnston, D
    Chen, M
    [J]. JOURNAL OF UROLOGY, 2000, 163 (01) : 152 - 157
  • [5] TUMOR VOLUME AND PROSTATE-SPECIFIC ANTIGEN - IMPLICATIONS FOR EARLY DETECTION AND DEFINING A WINDOW OF CURABILITY
    BABAIAN, RJ
    TRONCOSO, P
    STEELHAMMER, LC
    LLORETATRULL, J
    RAMIREZ, EI
    [J]. JOURNAL OF UROLOGY, 1995, 154 (05) : 1808 - 1812
  • [6] STAGING OF EARLY PROSTATE-CANCER - A PROPOSED TUMOR VOLUME-BASED PROGNOSTIC INDEX
    BOSTWICK, DG
    GRAHAM, SD
    NAPALKOV, P
    ABRAHAMSSON, PA
    DISANTAGNESE, PA
    ALGABA, F
    HOISAETER, PA
    LEE, F
    LITTRUP, P
    MOSTOFI, FK
    DENIS, L
    SCHROEDER, F
    MURPHY, GP
    [J]. UROLOGY, 1993, 41 (05) : 403 - 411
  • [7] Twelve prostate biopsies detect significant cancer volumes (&gt; 0.5 mL)
    Brössner, C
    Bayer, G
    Madersbacher, S
    Kuber, W
    Klingler, C
    Pycha, A
    [J]. BJU INTERNATIONAL, 2000, 85 (06) : 705 - 707
  • [8] Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?
    Chan, TY
    Chan, DY
    Lecksell, K
    Stutzman, RE
    Epstein, JI
    [J]. JOURNAL OF UROLOGY, 2001, 166 (06) : 2181 - 2184
  • [9] A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume
    Chen, ME
    Johnston, D
    Reyes, AO
    Soto, CP
    Babaian, RJ
    Troncoso, P
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (10) : 1291 - 1301
  • [10] Prostate cancer detection: Relationship to prostate size
    Chen, ME
    Troncoso, P
    Johnston, D
    Tang, K
    Babaian, RJ
    [J]. UROLOGY, 1999, 53 (04) : 764 - 768